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Abstract
Background: Except for terminal deletions that lead to Jacobsen syndrome, interstitial deletions involving the long
arm of chromosome 11 are not frequently reported. A clinically distinct phenotype is usually observed in these
cases, and no clear genotype-phenotype correlation is proposed.
Results: Here we present a case study of a 5-year-old girl with de novo submicroscopic deletion of chromosome
11q22.3 with mild mental retardation and facial dysmorphism. A standard cytogenetic analysis did not reveal any
structural aberrations. In contrary, array-CGH analysis indicated a small deletion of 11q22.3.
Discussion: To our knowledge, this is the smallest 11q22.3 deletion reported in literature, containing nine RefSeq
genes. Although none of the deleted genes are obvious candidates for the features observed in our patient, genes
CUL5 and SLN could play a key role in the features described.
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Background
Interstitial deletions of the long arm of chromosome 11
are not often reported in literature. Usually, the terminal
deletions that cause Jacobsen syndrome are well-
described, whereas interstitial aberrations are less well-
defined due to the band pattern similarity in this region
and limited resolution offered by classical cytogenetic
methods [1,2].
The clinical phenotype in 11q deletion patients usually
varies depending on the size and position of the dele-
tion. The same trend can be observed when 11q22.3
deletions are compared. No clear genotype-phenotype
correlation can be observed, mainly because the dele-
tions encompassing this region also include other bands
[1-12]. The most common phenotypic features observed
in these patients are mild to severe mental retardation,
developmental delay, a high arched or cleft palate (in
some cases with a cleft lip), and hypertelorism. A delay
in speech and walking are usually present in all cases
[1,2,8,10,11]. Additional features such as trigonocephaly
[10,11], small hands and feet [8,11], syndactyly [1],
simian crease [2,10], and others are also observed. To
the best of our knowledge a case with a deletion limited
to 11q22.3 has so far not been reported.
Here we present a girl with de novo submicroscopic
deletion of 11q22.3, detected by array-CGH analysis
(aCGH). Despite the fact that only much larger deletions
have been described previously, we propose a genotype-
phenotype correlation for this region. Hopefully, the dis-
covery of new patients with microdeletions in 11q22.3
will lead to a better understanding of the roles that the
deleted genes play in the clinical outcome.
Case presentation
An infant girl was born at 36 weeks gestation to a
healthy 23-year-old mother and 28-year-old father. Her
birth weight was 2690 g (50
th centile for gestational
age), her birth length was 47 cm (25
th centile), her head
circumference was 32.5 cm (25
th centile) and her Apgar
score was 9/9. After the birth there were no major con-
cerns, although patent ductus arteriosus and haemody-
namically significant atrial septal defect (ASD) had been
diagnosed, and pronounced dysmorphic features had
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fissures with ptosis of both. This was more pronounced
in the left upper palpable. Hypertelorism was also
observed and the nose was small in size and saddle-
shaped. She had a prominent frontal part of the skull,
giving the false impression of macrocrania. Her ears
were low-set, asymmetrical, triangular and slightly pro-
tuberant. Both lips were accentuated in shape and some-
times stretched in an asymmetrical manner (Figure 1). A
high-arched palate was also observed. There was evi-
dence of general muscular hypotonia and her develop-
mental milestones were delayed. She sat up without
help at 12 months and started walking at 18 months.
Her speech development was also late, and only devel-
oped after she was three years old. Her social and psy-
chical development were surprisingly good. A magnetic
resonance imaging (MRI) scan of the brain showed
hyperintensive changes in the white matter and hypo-
plastic corpus callosum. The electroencephalogram
(EEG) was normal and there were no convulsions.
At 12 months, she suffered from serious acute pyelo-
nephritis, and bilateral vesicoureteral reflux (VUR) was
diagnosed thereafter. The ultrasound kidney volumes
were normal with no major dilatation of the renal pye-
lon. The endoscopic treatment of the VUR was per-
formed on two occasions. Lastly, after classical surgical
treatment, the VUR was successfully treated. At that
time, her neurodevelopment was equivalent to that of a
9-month-old infant.
Assessments of the child are being carried out every
six months. With the exception of one case of pneumo-
nia and one case of acute laryngitis, no additional health
problems had been reported. There were no recurrent
urinary tract infections.
The girl is currently 5 years old. She weighs 15.5 kg
(10
th centile), has a height of 110 cm (50
th centile) and a
head circumference of 49 cm (10
th centile). The dys-
morphic features are still prominent. She has lower
basic muscle tone, especially in the shoulder muscles
and the pelvic girdle. Her muscle strength is fairly good
and her reflexes are normal. There are no major pro-
blems with fine motorics and there are no abnormal
movements or contractures. Her palms, especially
hypothenar, are hypoplastic and her fingers are thin.
Her foot arches are prominent. Hips incline to internal
r o t a t i o nw i t hk n e e sa d d u c t i o na n di n w a r df e e tr o t a t i o n ,
which has no major impact on her gait. Both renal func-
tion and blood pressure are normal. At present, she is
preparing for the correction of a congenital heart defect.
She is managed with a team of experts and receives
special logopaedic, psychological, and defectological
assistance. The girl is motivated, cooperates and strives
for success and progress. She is pleasant, friendly, good-
natured and no emotional or behavioural problems have
been observed. Despite her relatively normal develop-
ment, a psychological examination (Goodenough Draw,
Gessell Drawing Test, Brunet-Lesine scale, Vineland
Social Maturity Scale, Wechsler Intelligence Scale for
Children - WISC) reveals some cognition deficits and
borderline intellectual functioning, requiring specialised
help and causing delays in her formal education. She
follows and understands simple instructions, speaks in
sentences, but her pronunciation is unclear. Her global
intelligence quotient is 76 (WISC test). Her social
maturity meets the requirements of a 5-year-old child
(Vineland Social Maturity Scale). According to the Bru-
net-Lezine scale, her mental age is that of a 4.6 year old
child.
Results
As conventional karyotyping of the proband did not
reveal any structural rearrangements, the karyotype was
therefore determined to be 46, XX. Molecular karyotyp-
ing was performed on the Agilent 60K platform. Data
analyses indicated a 743 kb deletion of 11q22.3 (Figure
2). An aCGH analysis of the patients’ parents did not
show any abnormalities; thus deletion has been deter-
mined to be de novo. Confirmation of the deletion was
Figure 1 The facial features observed in our patient include ptosis, hypertelorism, low-set dysplastic ears and a prominent forehead.
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using BAC probe RP11-56J3. A single red signal can be
seen on the normal chromosome 11 and in the nucleus,
whereas the signal is absent in the chromosome with
the 11q22.3 deletion (Figure 3).
Discussion
In the relevant literature, deletions involving the long
arm of chromosome 11 are usually associated with
Jacobsen syndrome, a condition with multiple anomalies
caused by the terminal deletion of this chromosome
[13]. In contrast, interstitial deletions of 11q are less
common and often not fine-mapped, due to the similar-
ity between two band patterns (11q14 and 11q22) when
conventional karyotyping is performed [1,2]. Further-
more, no clear genotype-phenotype correlations have
been proposed in reported patients. Here, we present a
new patient with de novo submicroscopic deletion of
chromosome 11q22.3. The deletion was determined by
aCGH (Figure 2) and confirmed by a FISH analysis (Fig-
ure 3). The clinical phenotype in our patient includes
mild mental, developmental and speech delay, without
Figure 2 An aCGH analysis of the patient revealed a deletion of the 11q22.3 region. The breakpoints of the deletion were therefore
determined to be arr 11q22.3(107349817-108093259)x1 dn (hg19; NCBI build 37).
Figure 3 A FISH analysis of the patient was carried out using BAC probe RP11-56J3 (labelled red) encompassing the 11q22.3 region.A
single red signal can be seen on the normal chromosome 11 and in the nucleus, whereas the signal is absent in the chromosome with the
11q22.3 deletion.
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nent facial dysmorphisms, ptosis, hypertelorism, low-set
dysplastic ears and a prominent forehead (Figure 1).
Hypoplastic corpus callosum, VUR and ASD were also
diagnosed.
Much larger deletions, overlapping this region, have
been described previously. To our knowledge, none of
the reported cases had deletion limited only to 11q22.3;
therefore, this is the smallest deletion of 11q22.3
reported in the literature. Most of the patients with an
overlapping deletion of this region had mild to severe
mental retardation and developmental delay, usually
depending on the size and position of the deletion. A
high arched or cleft palate was observed in all cases.
Dysmorphic features such as trigonocephaly, microce-
phaly, hypertelorism, eye anomalies, hypotonia, speech
delay and others were also observed [1-12].
Apart from unspecific features, such as mental and
developmental delay, and eye and palate anomalies, no
specific common features were observed in our case
study or those previously described. Interestingly, the
Decipher patient 950 with a small inherited duplication
of this region (arr 11q22.3(107792125-107953547)x3 pat
(hg19; NCBI build 37)) has concordant phenotypic fea-
tures with our patient, including strabismus, kidney
anomalies, and hypoplastic corpus callosum, all of which
have not been observed in other cases.
The deletion interval in our case contains nine RefSeq
genes: ALKBH8, ELMOD1, LOC643923, SLN, SLC35F2,
RAB39, CUL5, ACAT1 and NPAT.T h eALKBH8 gene
encodes the ALKBH8 protein, which belongs to a group
of human homologues of AlkB protein in E. coli.
ALKBH8 is involved in the repair of methylation-
induced DNA damage by oxidative demethylation [14].
Its role was described in the prevention of mutation and
carcinogenesis in various types of mammalian cells
[15,16]. Secondly, the ELMOD1 gene encodes a
GTPase-activating protein. As ELMOD2 protein,
another member of ELMO family, ELMOD1 acts on the
Arf family, which are members of the Ras superfamily of
proteins [17]. The LOC643923 gene encodes a hypothe-
tical protein. Another gene, SLN, encodes a small pro-
teolipid that catalyses the ATP-dependent transport of
Ca(2+) from the cytosol into the lumen of the sarcoplas-
mic reticulum in muscle cells [18]. Although, Sln-null
mice do not exhibit any cardiac anomalies, a study from
Babu et al., 2007, demonstrated that homozygous-null
mice exhibit increased cardiac contractility [19]. The
SLC35F2 gene encodes a member of nucleotide sugar
transporters in the Golgi apparatus and the endoplasmic
reticulum [20]. A member of the Ras-like family,
involved in vesicle budding, docking, and fusion in
endocytosis and exocytosis pathways, is encoded by the
RAB39 gene [21-24]. The CUL5 gene encodes
vasopressin-activated calcium-mobilising receptor 1,
which is a component of a multiple SCF-like ECS E3
ubiquitin-protein ligase complex. This complex mediates
the ubiquitination and subsequent proteasomal degrada-
tion of target proteins [25,26]. The enzyme encoded by
the ACAT1 gene is involved in the metabolism of
acetyl-CoA. An autosomal recessive beta-ketothiolase
deficiency is described as an inborn error of isoleucine
catabolism caused by the disruption of this gene [27].
The last, NPAT gene, encodes the nuclear protein of the
ataxia telangiectasia mutated locus. This is a housekeep-
ing gene involved in the cell cycle. Imai et al., 1997, pro-
posed that the NPAT gene shares the same promoter
region with the ATM gene, the disruption of which
causes an autosomal recessive ataxia telangiectasia. A
loss of heterozygosity of this gene along with others on
11q22-q24 locus has been frequently described in var-
ious types of tumours [28].
Although none of the genes described previously indi-
cate their direct role in the development of phenotype
seen in our patient, Feng et al., 2007, reported that the
CUL5 gene plays an essential role in neuron migration
during cortical development [29]. The haploinsufficiency
of this gene has not yet been reported in patients or
knockout mice; therefore, a direct genotype-phenotype
correlation is not possible and further investigation
should be conducted. A lower expression of the SLN
gene was described in children with congenital heart
defects by Vittoius et al., 2007, but not in the associa-
tion with ASD [30].
Conclusion
The majority of the patients reported previously with
the deletion containing the 11q22.3 region display men-
tal retardation and facial dysmorphism, including the
patient presented here. Specific features such as strabis-
mus, kidney anomalies, and hypoplastic corpus callosum
are observed only in Decipher patient 950 and our
patient. Both of these probands have aberrations which
are limited only to 11q22.3.
None of the deleted genes are obvious candidates for
the features observed in our patient, although genes
CUL5 and SLN could play a key role in the features
described. The scarcity of patients with 11q22.3 micro-
deletions aggravates a clear genotype-phenotype correla-
tion. Hopefully, the discovery of new patients with
microdeletions in this region will lead to a better under-
standing of the roles that the deleted genes play in the
clinical outcome.
Materials and methods
Chromosome analysis
The chromosomal analysis was performed on metaphase
chromosomes using peripheral blood lymphocytes. The
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dance with standard cytogenetic methods.
Molecular karyotyping
Molecular karyotyping was performed on DNA
extracted from peripheral blood leukocytes of both, the
patient and her parents. An aCGH analysis was per-
formed using Agilent SurePrint G3 Human CGH Micro-
array Kit 8 × 60K (Agilent Technologies, Santa Clara,
CA, USA). The assay was performed according to the
manufacturers’ instructions with minor modifications.
The obtained data was analysed using the arrayCGHbase
software tool [31]. The DECIPHER [32] and ISCA [33]
databases were used for the genotype-phenotype
correlations.
FISH analysis
The fluorescent in situ hybridisation (FISH) analysis was
performed using BAC probe RP11-56J3. The BAC clone
was selected from the human library RPCI-11 according
to the UCSC Human Genome Assembly (March 2006
release) [34].
Consent
Written informed consent was obtained from the par-
ents of the patient for publication of this case report
and accompanying images. A copy of written consent is
available for review by the Editor-in-Chief of this
journal.
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